The Pharmaceutical Market: Brazil

Date: January 31, 2013
Pages: 192
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PA8B66B0234EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Brazil
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BRAZIL

The Brazilian pharmaceutical market remains our favourite regional market in Latin America due to its large market size and strong domestic demand for innovative, high-tech products. The government i s increasing ly invest ing in the healthcare sector and pharmaceutical industry to reduce the financial burden of diseases , and the country's private healthcare sectors provide opportunities for foreign companies. However, the increasing d rug rebate level has significantly undermined the profits recorded by generic drugmakers. The more aggressive government techonology transfer deals with multinationals as well as the drug approval delays due to bureaucracy and staff shortages at ANVISA have also dampened multinationals' revenue-generating opportunities

Headline Expenditure Projections

Pharmaceuticals: BRL48.10bn (US$28.72bn) in 2011 to BRL51.76bn (US$25.88bn) in 2012; +7.6% in local currency terms and -9.9% in US dollars terms. Forecast down from Q 4 12 due to less optimistic industry projections.

Healthcare: BRL378.63bn (US$226.04bn) in 2011 to BRL416.46bn (US$208.23bn) in 2012; +10.0% in local currency terms and -7.9% in US dollars. Forecast upwards from Q 4 12 due to more optimistic historical data.

Medical Devices: BRL7.45bn (US$4.45bn) in 2011 to BRL8.31bn (US$4.15bn) in 2012; +11.5% in local currency terms and -6.6 in US dollars terms. Forecast revised down wards from Q 4 12 due to analyst intervention.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Brazil Pharmaceuticals And Healthcare Industry SWOT
    Brazil Political SWOT
    Brazil Economic SWOT
    Brazil Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Americas Pharmaceutical Risk/Reward Ratings, Q113

BRAZIL – MARKET SUMMARY

REGULATORY REGIME

    Intellectual Property Environment
    Counterfeits
    Compulsory Licensing
    Pricing Regime
    Reimbursement Regime
    Table: Medicines In The Partnership Deals
    OTC Regulations
    Advertising

INDUSTRY DEVELOPMENTS

    Epidemiology
    Healthcare Sector
    Healthcare Sector Funding
    Research And Development
    Biotechnology
    Clinical Trials
    Medical Devices Market
    Medical Device Industry – Recent Developments
    Medical Device Distribution

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Brazil Pharmaceutical Sales, Historical Data And Forecasts
    Key Growth Factors – Industry
    Table: Brazil Healthcare Expenditure Trends, Historical Data And Forecasts
    Table: Brazil Government Healthcare Expenditure Trends, Historical Data And Forecasts
    Table: Brazil Private Healthcare Expenditure Trends, Historical Data And Forecasts
    Key Growth Factors – Macroeconomic
    Table: Brazil – Economic Activity
    Prescription Drug Market Forecast
    Table: Brazil Prescription Drug Market Indicators, Historical Data And Forecasts
    Patented Drug Market Forecast
    Table: Brazil Patented Drug Market Indicators, Historical Data And Forecasts
    Generic Drug Market Forecast
    Table: Brazil Generics Drug Market Indicators, Historical Data And Forecasts
    Table: Cumulative Active Ingredients, Registrations & Presentations Of Generics, 2000-April 2012
    Table: Top-12 Leading Brands Losing Patent, 2012
    OTC Medicine Market Forecast
    Table: Brazil Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts
    Pharmaceutical Trade Forecast
    Table: Brazil Pharmaceutical Trade Data And Forecasts (US$mn)
    Table: Brazil Pharmaceutical Trade Data And Forecasts (BRLmn)
    Medical Device Market Forecast
    Table: Brazil Medical Device Market Indicators, Historical Data And Forecasts
    Other Healthcare Data
    Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

    Pharmaceutical Industry
    Top 20 Pharmaceutical Companies In Brazil By Sales In 2010
    Innovative Drugmakers
    Innovative Drugmakers – Recent Developments
    Table: Members of ABIMIP, 2011
    Table: Members Of INTERFARMA, 2011
    Generic Drugmakers
    Table: Members Of ALANAC, 2011
    Table: Members Of ALFOB, 2011
    Members Of Pró-Genéricos, 2011
    Hypermarcas’ Major Acquisitions, 2005-11
    Table: Hypermarcas’ Net Sales By Division, 2009-10 (R$mn)
    OTC Sector
    Pharmaceutical Distribution Sector
    Table: Members Of ABAFARMA, 2012
    Members Of ABRADILAN, 2012
    Profarma’s Net & Gross Sales, 2005-11 (R$mn)
    Table: Profarma’s Distribution Centres By Location, 2012
    Santa Cruz’s Distribution Centres By
    Pharmaceutical Retail Sector
    Table: ABRAFARMA’s Ranking Of Pharmacy Chains By Sales, 2010-11
    Table: ABRAFARMA’s Ranking Of Pharmacy Chains By Number Of Outlets, 2010-11
    Table: ABRAFARMA’s Financial Indicators, 2008-11
    Table: Members Of ABRAFARMA, 2012
    Table: Members Of ASSIFARMA, 2012
    Table: Members Of FEBRAFAR By Region, 2012
    Table: Pague Menos’ Gross Sales, 2000-11
    Table: RaiaDrogasil’s Gross Sales, 2001-11 (R$mn)
    Table: RaiaDrogasil’s Number Of Pharmacies, 2001-12

COMPANY PROFILES

    Aché/Biosintética
    EMS Sigma
    Eurofarma
    Medley
    Cristália
    Sanofi
    Pfizer
    Merck & Co
    Novartis
    GlaxoSmithKline
    Roche

DEMOGRAPHIC OUTLOOK

    Table: Brazil's Population By Age Group, 1990-2020 ('000)
    Table: Brazil's Population By Age Group, 1990-2020 (% of total)
    Table: Brazil's Key Population Ratios, 1990-2020
    Table: Brazil's Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceuticals Business Environment Ratings
    Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


Looking at Offshoring in the Pharmaceutical Industry US$ 300.00 Jun, 2011 · 50 pages
The Pharmaceutical Market: Chile US$ 1,295.00 Jan, 2013 · 141 pages
The Pharmaceutical Market: China US$ 1,295.00 Jan, 2013 · 118 pages
The Pharmaceutical Market: Colombia US$ 1,295.00 Jan, 2013 · 114 pages

Ask Your Question

The Pharmaceutical Market: Brazil
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: